On familiarity deficits in mild cognitive impairment: a reply to Migo and Westerberg

Salvador Algarabel1, Manuel Fuentes, Joaquín Escudero

  • 1a University of Valencia , Valencia , Spain.

Insights

Mild cognitive impairment (MCI) patients show familiarity deficits, supported by multiple replications and correlations with Alzheimer's disease biomarkers. This response addresses criticisms of previous findings.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Neurology

Background:

  • Mild cognitive impairment (MCI) is often a precursor to Alzheimer's disease.
  • Previous research indicated familiarity deficits in MCI patients, but findings have been debated.
  • Understanding cognitive changes in MCI is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To address criticisms regarding familiarity deficits in mild cognitive impairment (MCI).
  • To provide statistical justification for combining MCI samples in previous research.
  • To highlight recent evidence supporting familiarity deficits and their link to Alzheimer's biomarkers.

Main Methods:

  • Statistical analysis to justify sample combination in prior studies.
  • Review and synthesis of existing literature on familiarity deficits in MCI.
  • Reference to a new report correlating familiarity deficits with neuroimaging biomarkers.

Main Results:

  • The study reaffirms the presence of familiarity deficits in mild cognitive impairment (MCI).
  • Statistical methods used previously are justified for demonstrating reliable deficits.
  • A new report confirms familiarity deficits and links them to Alzheimer's disease (AD) biomarkers.

Conclusions:

  • The criticism of familiarity deficits in MCI is considered unfounded.
  • Familiarity deficits in MCI are a reliable finding, supported by replication.
  • These deficits correlate with structural imaging biomarkers of Alzheimer's disease, suggesting clinical relevance.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Interference and Decay01:16

Interference and Decay

Forgetting is a complex cognitive phenomenon influenced by several factors, among which interference and decay are particularly prominent. These processes explain why individuals often struggle to retrieve specific information from memory, leading to lapses in recall that can be observed in everyday situations.
Interference occurs when competing memories hinder the retrieval of particular information. It can be classified into two types: proactive and retroactive interference. Proactive...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Visual Agnosia01:12

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round end"...